Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
of proposed research programme (2000 words) • CV with a publication list • 2 referees, including one from your current or most recent employer To apply, please click “Apply Now
-
. The Boulard Group's research program explores the functional partitioning of mammalian genomes. Commonly referred to as epigenetic silencing, this biological process ensures the stable transcriptional silencing
-
strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health
-
are available from 1 July 2025 to 30 June 2026 in the first instance. Based in the interdisciplinary Living Systems Institute, the successful applicants will join a world-leading programme of investigations
-
well as programming skills. Publications in top-tier AI and NLP venues (e.g., NeurIPS, ICML, ICLR, JMLR, ACL, EMNLP, TACL) are considered a significant merit. Scientific interest and contributions in molecular
-
, or a related field. The applicant should be highly self-motivated and have a record of first-authored publications in respected journals. Statistical and programming skills, such as R and the use of UNIX
-
and animal-based models R or Python programming expertise is a plus, but not mandatory Excellent oral and written English language skills History of manuscript productivity is needed to be a competitive
-
interdisciplinary approaches in their research program. Excellent written and oral communication skills. To see the complete job description click here . To see more about team/Group Leader click here. About Working
-
background Programming skills in MATLAB and/or Python Good writing and oral presentation skills Eligibility requirements of MSCA: Research experience: Maximum of 8 years from the award of first PhD. N.B
-
care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we